Inventiva S.A.

NASDAQ:IVA

Biotechnology

Healthcare
$3.39 +0.42%

+$0.02 today

Market cap
$176.22M
Beta
0.88
P/E (TTM)
-5.5
EPS (TTM)
-$0.56
52W Low $2.85High $7.98

Volume 3.54M

Average 0.45M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$100.98M

FY 2025 · Annual

Investing Cash Flow

-$127.93M

FY 2025 · Annual

Financing Cash Flow

$232.00M

FY 2025 · Annual

+59.4% YoY

Cash Flow Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(49.64M)(54.27M)(110.43M)(184.21M)(340.16M)
Depreciation & Amortization(1.29M)1.7M2.6M5.2M3.22M
Deferred Income Tax(3.27M)(5.26M)(4.74M)(4.8M)(2.3M)
Stock-Based Compensation2.09M2.22M3.97M3.58M26.77M
Change in Working Capital979K5.71M17.31M1.68M6.42M
Accounts Receivables(5.32M)3.84M(5.84M)2.81M816.45K
Inventory(72K)19K(44K)417K0
Accounts Payables7.6M3.54M20M02.46M
Other Working Capital(1.23M)(1.69M)3.19M(1.54M)3.15M
Other Non-Cash Items3.5M4.98M9.68M92.63M205.07M
Operating Cash Flow(47.63M)(44.93M)(81.61M)(85.93M)(100.98M)
Capital Expenditures(534K)(561K)(540K)(333K)(237.26K)
Acquisitions (Net)89K41K000
Purchases of Investments(1.35M)(1K)(8.3M)0(127.69M)
Sales of Investments(89K)9.39M978K9.08M0
Other Investing Activities90K1K131K75.72K(1K)
Investing Cash Flow(1.79M)8.87M(7.73M)8.75M(127.93M)
Debt Repayment(28K)28.44M(4.1M)19.92M(5.98M)
Common Stock Issued25.48M8.83M28.08M57.34M237.74M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(17.73K)(772.47K)5.1M68.33M236.98K
Financing Cash Flow25.45M37.27M29.08M145.59M232M
Effect of Forex Changes4.84M(1.03M)445K1.24M11.08M
Net Change in Cash(19.13M)183K(59.82M)69.65M14.17M
Free Cash Flow(48.16M)(45.49M)(82.15M)(86.26M)(101.22M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$340.2M
+ D&A$3.2M
+ Stock-Based Comp$26.8M
- Deferred Tax-$2.3M
+ Working Capital$6.4M
+ Other Non-Cash$205.1M
= Operating Cash Flow-$101.0M
- Capex-$237.3K
= Free Cash Flow-$101.2M

Analysis

FY2025 free cash flow is -$101.2M. FCF conversion is 29.8% of net income. Operating cash flow was -$101.0M, with capex of -$237.3K. The largest bridge item is Other Non-Cash at $205.1M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingOct 27, 2026
6-K6-K filingOct 6, 2026
6-K6-K filingSep 28, 2026
6-K6-K filingSep 3, 2026
6-K6-K filingSep 1, 2026

Does IVA generate free cash flow?

Inventiva S.A. (IVA) generated -$101.22M of free cash flow in fiscal 2025.

How much operating cash flow does IVA produce?

Operating cash flow was -$100.98M, before capital expenditures of $237,255.00.